Although a link between cognition and APOE ε4 exists in patients with PD, our results suggest that APOE ε4 plays a secondary role when considering multiple factors such as depression, physical activity, and other nonmotor symptoms, which have a stronger impact on cognitive impairment. This evidence concerns the gene APOE and depressive symptom measurement.